By Fred Gardner Project CBD has just sent out its introductory pitch to California dispensaries.…
Tag: CBD
[Editor’s note: This post is excerpted from this week’s forthcoming NORML weekly media advisory. To…
Investigators and pundits alike are fond of calling for ‘more research’ into the safety and…
US News & World Report recently probed the subject of cannabis science, publishing a pair…
[Editor’s note: This post is excerpted from this today’s forthcoming NORML weekly media advisory. To…
Fifteen members of the Society of Cannabis Clinicians -the doctors’ group founded by Tod Mikuriya in 1999 and now led by Jeffrey Hergenrather- met in Oakland Dec. 11. UCSF professor Donald Abrams recounted the obstacles he faced in conducting clinical trials with government-issued cannabis and getting his results published in peer-reviewed medical journals. The ensuing discussion focused on how SCC doctors might go about evaluating the effectiveness of high-CBD strains as they become available to patients in the year ahead.
While the prohibition of cannabis is absurd, the ban on the plant’s non-psychoactive components is even more mind-boggling — particularly when it’s apparent that these compounds possess amazing therapeutic properties. Case in point: cannabidiol (CBD).
A just published scientific review by Sao Paulo University (Brazil) researcher Antonio Zuardi reports that there’s been an “explosive increase” of interest in CBD over the past five years. It’s apparent why.